<DOC>
	<DOCNO>NCT01117766</DOCNO>
	<brief_summary>Conventional pain efficacy measure Visual Analogue Scores ( VAS ) often unable detect treatment efficacy small-scale clinical trial . Combining conventional pain efficacy measure quantitative sensory testing ( QST ) may provide sensitive informative outcome measure clinical trial .</brief_summary>
	<brief_title>Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain</brief_title>
	<detailed_description>Methodology assess reproducibility sensitivity quantitative sensory test</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Neuropathic pain peripheral origin demonstrate spontaneous ongoing pain dynamic mechanical allodynia brush stimulus . A present pain intensity score 4 ( 10 ) spontaneous ongoing pain brushevoked allodynia skin area screen . Stable analgesic medication ( exclude pregabalin ) minimum 1 month prior start study . Patients undergone neurolytic neurosurgical therapy . Patients trigeminal neuralgia , central pain ( due cerebrovascular lesion , multiple sclerosis traumatic spinal cord injury ) , complex regional pain syndrome ( Type I II ) , phantom limb pain . Patients previously treat pregabalin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Methodology</keyword>
	<keyword>Quantitative Sensory Testing</keyword>
	<keyword>Neuropathies Pain</keyword>
	<keyword>Pregabalin</keyword>
</DOC>